Chimerix held its 2024 Annual Meeting on June 20, with 61,670,383 shares represented. Stockholders elected three Class II directors: Martha J. Demski, Pratik S. Multani, M.D., and Vicki Vakiener, each to serve until 2027. The 2024 Equity Incentive Plan was approved, and Ernst & Young LLP was ratified as the independent registered public accounting firm for FY2024.Stockholders also approved, on an advisory basis, the compensation of named executive officers. Additionally, the Board appointed Marc D. Kozin to the Audit Committee, filling the vacancy left by Patrick Machado's resignation. The meeting addressed key governance matters and demonstrated shareholder engagement in company decisions.

Chimerix held its 2024 Annual Meeting on June 20, with 61,670,383 shares represented. Stockholders elected three Class II directors: Martha J. Demski, Pratik S. Multani, M.D., and Vicki Vakiener, each to serve until 2027. The 2024 Equity Incentive Plan was approved, and Ernst & Young LLP was ratified as the independent registered public accounting firm for FY2024.Stockholders also approved, on an advisory basis, the compensation of named executive officers. Additionally, the Board appointed Marc D. Kozin to the Audit Committee, filling the vacancy left by Patrick Machado's resignation. The meeting addressed key governance matters and demonstrated shareholder engagement in company decisions.